Post-remission therapy with allogeneic stem cell transplantation from an HILA-matched family donor in younger patients with acute myeloid leukaemia exhibiting a normal karyotype:: differential effects of molecular markers

被引：0
|
作者：
Schlenk, RF
Corbacioglu, A
Krauter, J
Fröhling, S
Bunjes, D
Späth, D
Schäfer, I
Döhner, H
Ganser, A
Döhner, K
机构：
[1] Univ Ulm, Ulm, Germany
[2] Hannover Med Sch, D-3000 Hannover, Germany
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [31] Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors
    Brissot, Eolia
    Labopin, Myriam
    Moiseev, Ian
    Cornelissen, J. J.
    Meijer, Ellen
    Van Gorkom, Gwendolyn
    Rovira, Montserrat
    Ciceri, Fabio
    Griskevicius, Laimonas
    Blaise, Didier
    Forcade, Edouard
    Mistrik, Martin
    Mielke, Stephan
    Bulabois, Claude Eric
    Niittyvuopio, Riitta
    Deconinck, Eric
    Ruggeri, Annalisa
    Sanz, Jaime
    Spyridonidis, Alexandros
    Savani, Bipin
    Giebel, Sebastian
    Nagler, Arnon
    Mohty, Mohamad
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [32] Reduced-dose conditioning followed by allogeneic stem cell transplantation induces stable long-term remission in high-risk patients suffering from acute myeloid leukaemia
    Mügge, LO
    Weiss, K
    Wirth, K
    Schilling, K
    Scholl, S
    Charbel-Issa, M
    Höffken, K
    Sayer, HG
    BONE MARROW TRANSPLANTATION, 2004, 33 : S105 - S105
  • [33] Phase II study of azacitidine (Vidaza®, Aza) and donor lymphocyte infusions as first salvage therapy in patients with acute myeloid leukaemia or myelodysplastic syndromes relapsing after allogeneic haematopoietic stem cell transplantation
    Schroeder, T.
    Czibere, A.
    Kroeger, N.
    Platzbecker, U.
    Bug, G.
    Uharek, L.
    Luft, T.
    Wolschke, C.
    Fenk, R.
    Haas, R.
    Kobbe, G.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S42 - S43
  • [34] Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
    Poire, Xavier
    Labopin, Myriam
    Maertens, Johan
    Yakoub-Agha, Ibrahim
    Blaise, Didier
    Ifrah, Norbert
    Socie, Gerard
    Gedde-Dhal, Tobias
    Schaap, Nicolaas
    Cornelissen, Jan J.
    Vigouroux, Stephane
    Sanz, Jaime
    Michaux, Lucienne
    Esteve, Jordi
    Mohty, Mohamad
    Nagler, Arnon
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10 : 1 - 10
  • [35] Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
    Xavier Poiré
    Myriam Labopin
    Johan Maertens
    Ibrahim Yakoub-Agha
    Didier Blaise
    Norbert Ifrah
    Gérard Socié
    Tobias Gedde-Dhal
    Nicolaas Schaap
    Jan J. Cornelissen
    Stéphane Vigouroux
    Jaime Sanz
    Lucienne Michaux
    Jordi Esteve
    Mohamad Mohty
    Arnon Nagler
    Journal of Hematology & Oncology, 10
  • [36] Impact of cytogenetics risk on outcome after reduced-intensity conditioning allogeneic stem cell transplantation from an HLA-identical sibling for patients with acute myeloid leukaemia in first complete remission
    Mohty, M.
    Labopin, M.
    Milpied, N.
    Cornelissen, J. J.
    Blaise, D.
    Petersen, E.
    Theorin, N.
    Goker, H.
    Socie, G.
    Rocha, V.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S66 - S66
  • [37] Risk Factors for Overall Survival in Patients with Acute Myeloid Leukemia (AML) with Normal Karyotype Undergoing Allogeneic Stem Cell Transplantation (allo-SCT) in First Complete Remission (CR1): A Report On 366 Patients From the Acute Leukemia Working Party of EBMT
    Schmid, Christoph
    Labopin, Myriam
    Deconinck, Eric
    Attal, Michel
    Socie, Gerard
    Vigouroux, Stephane
    Volin, Liisa
    Ifrah, Norbert
    Rambaldi, Alessandro
    Rossi, Jean-Francois
    Blaise, Didier
    Cornelissen, Jan
    Ljungman, Per T.
    Brune, Mats L.
    Bordigoni, Pierre
    Vernant, Jean-Paul
    Yakoub-Agha, Ibrahim
    Pogliani, Enrico Maria
    Michallet, Mauricette
    Arcese, William
    Polge, Emmanuelle
    Esteve, Jordi
    Mohty, Mohamad
    BLOOD, 2012, 120 (21)
  • [38] Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial
    Chevallier, P.
    Fornecker, L.
    Lioure, B.
    Bene, M. C.
    Pigneux, A.
    Recher, C.
    Witz, B.
    Fegueux, N.
    Bulabois, C-E
    Daliphard, S.
    Bouscary, D.
    Vey, N.
    Delain, M.
    Bay, J-O
    Turlure, P.
    Bernard, M.
    Himberlin, C.
    Luquet, I.
    Ifrah, N.
    Harousseau, J-L
    LEUKEMIA, 2010, 24 (07) : 1380 - 1385
  • [39] Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial
    P Chevallier
    L Fornecker
    B Lioure
    M C Béné
    A Pigneux
    C Recher
    B Witz
    N Fegueux
    C-E Bulabois
    S Daliphard
    D Bouscary
    N Vey
    M Delain
    J-O Bay
    P Turlure
    M Bernard
    C Himberlin
    I Luquet
    N Ifrah
    J-L Harousseau
    Leukemia, 2010, 24 : 1380 - 1385
  • [40] Allogeneic peripheral blood stem cell transplantation from HLA-identical siblings versus allelic-matched unrelated donors in patients with acute myeloid leukaemia and myelodysplasic syndrome after reduced-intensity conditioning
    Robin, M.
    Porcher, R.
    Ades, L.
    Raffoux, E.
    Boissel, N.
    Larghero, J.
    Himberlin, C.
    Gardin, C.
    Delmer, A.
    Fenaux, P.
    Dombret, H.
    Socie, G.
    de latour, R. Peffault
    BONE MARROW TRANSPLANTATION, 2012, 47 : S66 - S66
12345